We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 52 start-ups with an aggregate funding of $2.6b. The average funding per company in this subset is $50.6m.
Last update to the database: Feb 18, 2025. See changelog.
3
Funding Rounds
$34.0m
Money raised
Paradromics is an Austin, Texas-based company developing a high-volume bidirectional data streaming capabilities between brains and computers.
3
Funding Rounds
$125.0m
Money raised
Synchron, Inc. is a technology company building implantable neural interface solutions, including endovascular brain-computer interface.
3
Funding Rounds
$145.0m
Money raised
Cala Health offers bioelectronic medicines, medical devices, and neurotherapeutics for managing chronic health conditions.
5
Funding Rounds
$134.1m
Money raised
Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.
2
Funding Rounds
$25.0m
Money raised
Reverie Labs is a drug dicovery company that uses machine learning founded by Jonah Kallenbach.
3
Funding Rounds
$15.1m
Money raised
CB Therapeutics is a biotechnology company focused on the biosynthetic production of cannabinoids from sugar.
1
Funding Rounds
$44.0m
Money raised
Annexon Biosciences is a South San Francisco, California-based biotechnology company working on discovering and developing therapeutics for neurodegenerative and autoimmune disorders.
2
Funding Rounds
$21.2m
Money raised
Q-State is a therapeutics company that facilitates programs for the treatment of epilepsy, pains and other diseases of the central nervous system.
3
Funding Rounds
$26.3m
Money raised
Creating a New Gold Standard in Brain Health With Precision Neurology.
4
Funding Rounds
$160.0m
Money raised
Mindstrong Health is a neuroscience precision therapy company founded in 2014 by Paul Dagum.
2
Funding Rounds
$100.0m
Money raised
Delix Therapeutics is a CNS-focused drug discovery company.
2
Funding Rounds
$20.0m
Money raised
Bionaut Labs develops precision medicine treatments for CNS disorders.
2
Funding Rounds
$140.0m
Money raised
Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.
13
Funding Rounds
$147.7m
Money raised
Minoryx Therapeutics is a small Molecules for Rare Diseases founded in 2011.
4
Funding Rounds
$62.7m
Money raised
CODA Biotherapeutics, Inc. is a biopharmaceutical company that develops an innovative gene therapy platform for treating neurological disorders and diseases.
4
Funding Rounds
$34.6m
Money raised
Rune Labs is a software and data platform for neuromodulation founded in 2018 by Brian Pepin.
4
Funding Rounds
$17.5m
Money raised
Quadrant Biosciences Inc is a Syracuse, New York-based medical diagnostics company developing solutions for head injury assessment and autism detection founded in 2011 by Richard Uhlig.
2
Funding Rounds
$55.2m
Money raised
Xalud Therapeutics is a neuropathic pain therapies.
1
Funding Rounds
$13.0m
Money raised
Chronos is an Oxford-based biotechnology company operating a semi-virtual R&D model to develop a portfolio of therapies in degenerative and behavioral brain diseases.
1
Funding Rounds
$83.0m
Money raised
Nitrase Therapeutics is a Brisbane, California-based company offering a biopharmaceutical platform, Nitrome, designed to offer therapies against a broad variety of diseases.
2
Funding Rounds
$6.0m
Money raised
Tetra Therapeutics is a Grand Rapids, Michigan-based biotechnology company developing drugs for brain-related diseases.
1
Funding Rounds
$55.0m
Money raised
Linus Health is a company founded in 2019.
3
Funding Rounds
$514.0k
Money raised
Brain Scientific is a healthcare company that offers modern solutions to the neurology industry.
2
Funding Rounds
$25.0m
Money raised
Stalicla is a Geneva-based company developing a drug development platform for neurodevelopmental disorders.
3
Funding Rounds
$117.0m
Money raised
Neurostimulation device
2
Funding Rounds
$180.0m
Money raised
Neuron23 is an AI-drug discovery founded in 2018 by Adam Knight.
1
Funding Rounds
$26.0m
Money raised
A biopharmaceutical company developing therapiesfor the treatment of central nervous system disorders
2
Funding Rounds
$20.5m
Money raised
RedPin Therapeutics a preclinical stage gene therapy company based in New York City.
2
Funding Rounds
$30.0m
Money raised
Coya Therapeutics develops treatments that target regulatory T cells, or Tregs, to treat Alzheimer's and ALS.
3
Funding Rounds
$33.6m
Money raised
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
1
Funding Rounds
$15.0m
Money raised
Noveome Biotherapeutics, Inc. is a biotechnology research company focused on therapies for the regenerative repair of inflamed or damaged tissue.
4
Funding Rounds
$12.3m
Money raised
Alpha Cognition is a clinical stage, biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS).
1
Funding Rounds
$18.0m
Money raised
CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as well as several orphan indications
2
Funding Rounds
$4.9m
Money raised
A company developing treatments for central nervous system related diseases and injuries
2
Funding Rounds
$80.0m
Money raised
Cadent Therapeutics was a Cambridge, Massachusetts-based precision neuroscience company developing drugs for the treatment of psychiatric diseases The company was acquired by Novartis in December 2020.
2
Funding Rounds
$9.0m
Money raised
TheraVida is a company developing therapies for hyperhidrosis.
1
Funding Rounds
$6.6m
Money raised
A medical technology companythat develops therapies for acute ischemic stroke and other vascular disorders
3
Funding Rounds
$257.5m
Money raised
A company deveoping treatments for Alzheimer's disease and other neurological conditions
2
Funding Rounds
$12.0m
Money raised
Q Therapeutics is a CNS Therapies.
2
Funding Rounds
$10.0m
Money raised
A biopharmaceutical company developing biologics and small molecules for treating central nervous system conditions
2
Funding Rounds
$2.7m
Money raised
Cognos Therapeutics creates technologies to advance the diagnosis and treatment of neuropathic diseases.
1
Funding Rounds
$1.4m
Money raised
A company developing diagnostic medical devices for the detection of cerebrospinal fluid leaks and early-stage prostate cancer
1
Funding Rounds
Vivid Genomics is a San Diego-based drug development company focused on neurodegenerative diseases.
2
Funding Rounds
$82.5m
Money raised
MycoMedica Life Sciences, PBC is a company founded in 2021.
2
Funding Rounds
$64.0m
Money raised
Engrail Therapeutics is a treatments for Life-Limiting Diseases.
2
Funding Rounds
$5.2m
Money raised
Circular Genomics Inc. is an Albuquerque, New Mexico-based company founded in 2021.
1
Funding Rounds
$50.0m
Money raised
Retrotope Inc. is a Los Altos, California-based company founded in 2006.
1
Funding Rounds
$63.0m
Money raised
E-Scape Bio is a South San Francisco, California-based company founded in 2015.
1
Funding Rounds
$5.0m
Money raised
MedGenesis Therapeutix is a neurologic Treatment - 'Convection Enhanced Delivery.
1
Funding Rounds
$17.9m
Money raised
Magnolia Neurosciences is a Seattle-based company founded in 2018.
1
Funding Rounds
$5.0m
Money raised
Amylyx is a Cambridge, Massachusetts-based company.
1
Funding Rounds
$12.0m
Money raised
Cleave Therapeutics is a protein degradation inhibitors.
Enter your email and get access to 71,000 + technology companies you can partner with.